EDGAR Filing Documents for 0001052918-21-000261

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001052918-21-000261

Filing Date

2021-07-08

Accepted

2021-07-08 15:10:51

Documents

Period of Report

2021-05-31

Document Format Files

Seq	Description	Document	Type	Size
1	AVRICORE HEALTH INC.	avricore6kmay2021.htm	6-K	11213
2	EXHIBIT 99.1	nr_ex99z1.htm	EX-99.1	10328
3	EXHIBIT 99.2	fs_ex99z2.htm	EX-99.2	202488
4	EXHIBIT 99.3	mda_ex99z3.htm	EX-99.3	99749
5	EXHIBIT 99.4	ceocert_ex99z4.htm	EX-99.4	6102
6	EXHIBIT 99.5	cfocert_ex99z5.htm	EX-99.5	6137
7	IMAGE	nrex99z1_1.jpg	GRAPHIC	4761
8	IMAGE	fsex99z2_1.jpg	GRAPHIC	4761
9	IMAGE	mdaex99z3_1.jpg	GRAPHIC	4761
	Complete submission text file	0001052918-21-000261.txt		357440

Mailing Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2

Business Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2 604-687-2038

Avricore Health Inc. (Filer) CIK: 0001355736 (see all company filings)